Immediate Release: February 6, 2003
SOPHEON PLC
('Sopheon')
UPDATE
Sopheon plc advises the market that is not aware of any corporate actions which
could be the cause of the recent movement in its share price. While very
encouraged by the rise, Sopheon emphasises that it has limited recent corporate
activities to matters outstanding from 2003 divestments, and to supporting its
balance sheet position. Key examples are ongoing negotiations over earnouts and
asset transfer values with the purchaser of the group's Information Management
business, negotiation and conclusion of a €10m equity line facility with GEM
Global Yield Fund Limited, and the recent placing of 3,600,000 shares for gross
proceeds of £828,000.
The board remains committed to delivering Sopheon's long-term business
objectives and is encouraged by the positive effect on the business of the
significant corporate activity undertaken over the last 12 months. Management
is focused on building on the positive developments of the final quarter of
2003, in a market in which the investment climate and the quality of sales
pipeline activity continue to show real signs of improvement over previous
periods.
The company intends to release its 2003 preliminary results around the end of
March, and will make further announcements when a date is confirmed.
For further information contact:
Barry Mence, Chairman Sopheon plc Tel : + 44 (0) 1483 685
735
Arif Karimjee, CFO
Adam Reynolds Hansard Communications Tel : + 44 (0) 207 245
1100
Andrew Tan
+ 44 (0) 7957 203 685
Barbara Jansen Citigate First Financial Tel : + 31 (0) 205 754 010
About Sopheon
Sopheon (LSE: SPE) is an international provider of software and services that
help organizations improve the business impact of product development. The
Sopheon Accolade® product development system automates gate- or phase-based
product development processes and provides strategic decision support that
allows companies to improve innovation, cut product development spending waste
and shorten time to market. Sopheon's Monitor software operates as a 'reading
robot' that automatically reviews, filters, analyzes and pushes relevant
content to healthcare and engineering professionals to enable effective
compliance with protocols, standards and regulations. Sopheon is listed on the
AIM Market of the London Stock Exchange and on the Euronext in the Netherlands.
For more information, please visit www.sopheon.com.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.